AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+10.88%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.61B
AUM Growth
+$1.61B
(+18%)
Cap. Flow
+$49.7M
Cap. Flow
% of AUM
3.09%
Top 10 Holdings %
Top 10 Hldgs %
87.2%
Holding
88
New
12
Increased
7
Reduced
4
Closed
9
Top Buys
| 1 |
Alibaba
BABA
|
$53.3M |
| 2 |
WW
WW International
WW
|
$19M |
| 3 |
Mastercard
MA
|
$12.9M |
| 4 |
Delta Air Lines
DAL
|
$10.8M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
$6.86M |
Top Sells
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$30.3M |
| 2 |
Amazon
AMZN
|
$16.2M |
| 3 |
Citigroup
C
|
$14.1M |
| 4 |
Terex
TEX
|
$8.22M |
| 5 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$5.93M |
Sector Composition
| 1 | Consumer Discretionary | 55.71% |
| 2 | Healthcare | 35.03% |
| 3 | Financials | 1.36% |
| 4 | Technology | 0.96% |
| 5 | Industrials | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $808M | 29.73% | 29,443,300 +694,211 | +2% | +$19M |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $357M | 13.15% | 253,372,135 | – | – |
|
|
3
Alibaba
BABA
$322B
| $53.3M | 1.96% | +600,000 | New | +$53.3M |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $39.7M | 1.46% | 550,000 +25,000 | +5% | +$1.8M |
|
|
AUXL
5
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $29.9M | 1.1% | 1,000,000 -1,015,000 | -50% | -$30.3M |
|
|
PCYC
6
DELISTED
PHARMACYCLICS INC
PCYC
| $26.4M | 0.97% | 225,000 -45,000 | -17% | -$5.28M |
|
|
AVNR
7
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $23.8M | 0.88% | 2,000,000 | – | – |
|
8
Alnylam Pharmaceuticals
ALNY
$58.5B
| $23.4M | 0.86% | 300,000 | – | – |
|
9
Incyte
INCY
$16.5B
| $21.6M | 0.79% | 440,000 +60,000 | +16% | +$2.94M |
|
10
Nektar Therapeutics
NKTR
$568M
| $19.9M | 0.73% | 1,650,000 +300,000 | +22% | +$3.62M |
|
11
Ionis Pharmaceuticals
IONS
$6.79B
| $17.7M | 0.65% | 455,000 | – | – |
|
|
IMGN
12
DELISTED
Immunogen Inc
IMGN
| $15.9M | 0.58% | 1,500,000 | – | – |
|
|
13
Mastercard
MA
$538B
| $12.9M | 0.48% | +175,000 | New | +$12.9M |
|
14
Aptiv
APTV
$17.3B
| $12.3M | 0.45% | 200,000 +50,000 | +33% | +$3.07M |
|
15
Agios Pharmaceuticals
AGIO
$2.19B
| $11.7M | 0.43% | 190,000 +15,000 | +9% | +$920K |
|
|
16
Delta Air Lines
DAL
$40.3B
| $10.8M | 0.4% | +300,000 | New | +$10.8M |
|
|
ARRY
17
DELISTED
Array Biopharma Inc
ARRY
| $10.7M | 0.39% | 3,000,000 | – | – |
|
18
General Motors
GM
$55.8B
| $9.58M | 0.35% | 300,000 -50,000 | -14% | -$1.6M |
|
|
BLUE
19
DELISTED
bluebird bio
BLUE
| $8.97M | 0.33% | 250,000 | – | – |
|
|
ACOR
20
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $8.47M | 0.31% | 250,000 -175,000 | -41% | -$5.93M |
|
|
TFCFA
21
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $6.86M | 0.25% | +200,000 | New | +$6.86M |
|
|
FSL
22
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $6.84M | 0.25% | +350,000 | New | +$6.84M |
|
|
KITE
23
DELISTED
Kite Pharma, Inc.
KITE
| $5.99M | 0.22% | +210,000 | New | +$5.99M |
|
24
Harley-Davidson
HOG
$3.54B
| $5.82M | 0.21% | +100,000 | New | +$5.82M |
|
25
American International
AIG
$45.1B
| $5.4M | 0.2% | 100,000 | – | – |
|